Improved protection by recombinant BCG

Microbes and Infection

Volumn 7, Issue 5-6, 2005, Pages 939-946

  Eddine, Ali Nasser ^a   Kaufmann, Stefan H E ^a  

^a MAX PLANCK INSTITUTE FOR INFECTION BIOLOGY   (Germany)

Author keywords

Bacille Calmette Gu rin (BCG); Improved immunogenicity; Mycobacterium bovis; rBCG

Indexed keywords

BACTERIAL ANTIGEN; BCG VACCINE; CYTOKINE; CYTOLYSIN; LIVE VACCINE;

ANTIBODY LABELING; APOPTOSIS; AUXOTROPHIC MUTANT; BACTERIAL STRAIN; CELL STIMULATION; CORRELATION ANALYSIS; CYTOKINE PRODUCTION; DRUG SAFETY; GENOMICS; IMMUNE DEFICIENCY; IMMUNE RESPONSE; IMMUNITY; IMMUNOGENICITY; MEDICAL TECHNOLOGY; MUTAGENESIS; MYCOBACTERIUM BOVIS; PRIORITY JOURNAL; REVIEW; T LYMPHOCYTE ACTIVATION; TUBERCULOSIS;

MYCOBACTERIUM BOVIS;

EID: 20444471405     PISSN: 12864579     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.micinf.2005.03.012     Document Type: Short Survey

References (68)

1. B.R. Bloom, and P.E. Fine The BCG experience: implications for future vaccines against tuberculosis B.R. Bloom "Tuberculosis: Pathogenesis, Protection and Control" 1994 ASM Press Washington, DC 531 557
2. A. Calmette, C. Guerin, L. Negre, and A. Bocquet Sur la vaccination preventive des enfants nouveau-ńs contre la tuberculose par le BCG Ann. Inst. Pasteur (Paris) 3 1927 201 208
3. M.A. Behr, M.A. Wilson, W.P. Gill, H. Salamon, G.K. Schoolnik, S. Rane, and P.M. Small Comparative genomics of BCG vaccines by whole-genome DNA microarray Science 284 5419 1999 1520 1523
4. R. Brosch, A.S. Pym, S.V. Gordon, and S.T. Cole The evolution of mycobacterial pathogenicity: clues from comparative genomics Trends Microbiol. 9 9 2001 452 458
5. S.V. Gordon, R. Brosch, A. Billault, T. Garnier, K. Eiglmeier, and S.T. Cole Identification of variable regions in the genomes of tubercle bacilli using bacterial artificial chromosome arrays Mol. Microbiol. 32 3 1999 643 655
6. G.G. Mahairas, P.J. Sabo, M.J. Hickey, D.C. Singh, and C.K. Stover Molecular analysis of genetic differences between Mycobacterium bovis BCG and virulent M. bovis J. Bacteriol. 178 5 1996 1274 1282
7. P.R. Jungblut, E.C. Muller, J. Mattow, and S.H.E. Kaufmann Proteomics reveals open reading frames in Mycobacterium tuberculosis H37Rv not predicted by genomics Infect. Immun. 69 9 2001 5905 5907
8. S.T. Cole, R. Brosch, J. Parkhill, T. Garnier, C. Churcher, D. Harris, S.V. Gordon, K. Eiglmeier, S. Gas, C.E. Barry III, F. Tekaia, K. Badcock, D. Basham, D. Brown, T. Chillingworth, R. Connor, R. Davies, K. Devlin, T. Feltwell, S. Gentles, N. Hamlin, S. Holroyd, T. Hornsby, K. Jagels, A. Krogh, J. McLean, S. Moule, L. Murphy, K. Oliver, J. Osborne, M.A. Quail, M.A. Rajandream, J. Rogers, S. Rutter, K. Seeger, J. Skelton, R. Squares, S. Squares, J.E. Sulston, K. Taylor, S. Whitehead, and B.G. Barrell Deciphering the biology of Mycobacterium tuberculosis from the complete genome sequence Nature 393 6685 1998 537 544
9. G.A. Colditz, T.F. Brewer, C.S. Berkey, M.E. Wilson, E. Burdick, H.V. Fineberg, and F. Mosteller Efficacy of BCG vaccine in the prevention of tuberculosis. Meta-analysis of the published literature J. Am. Med. Assoc. 271 9 1994 698 702
10. R.E. Huebner BCG vaccination in the control of tuberculosis Curr. Top. Microbiol. Immunol. 215 1996 263 282
11. H. Scharkoff Evaluation of tuberculosis control in the region of the former East Germany 1945-1990 Offentl. Gesundheitswes. 53 8-9 1991 510 513
12. R. Schnorr The status of tuberculosis in the former GDR 1989 Pneumologie 44 11 1990 1245 1250
13. N.M. Parrish, J.D. Dick, and W.R. Bishai Mechanisms of latency in Mycobacterium tuberculosis Trends Microbiol. 6 3 1998 107 112
14. L. Brandt, J. Feino Cunha, A. Weinreich Olsen, B. Chilima, P. Hirsch, R. Appelberg, and P. Andersen Failure of the Mycobacterium bovis BCG vaccine: some species of environmental mycobacteria block multiplication of BCG and induction of protective immunity to tuberculosis Infect. Immun. 70 2 2002 672 678
15. P.E. Fine, I.A. Carneiro, J.B. Milstien, C.J. Clements, Issues Relating to the Use of BCG in Immunisation Programmes. WHO/V&B/99.23, 1999, pp. 1-45. Geneva, World Health Organisation, Department of Vaccines and Biologicals.
16. S.T. Cole Learning from the genome sequence of Mycobacterium tuberculosis H37Rv FEBS Lett. 452 1-2 1999 7 10
17. P. Andersen TB vaccines: progress and problems Trends Immunol. 22 3 2001 160 168
18. I.M. Orme Beyond BCG: the potential for a more effective TB vaccine Mol. Med. Today 5 11 1999 487 492
19. I. Guleria, R. Teitelbaum, R.A. McAdam, G. Kalpana, W.R. Jacobs, and B.R. Bloom Auxotrophic vaccines for tuberculosis Nat. Med. 2 3 1996 334 337
20. D.M. Collins New tuberculosis vaccines based on attenuated strains of the Mycobacterium tuberculosis complex Immunol. Cell Biol. 78 4 2000 342 348
21. M.A. Horwitz, G. Harth, and B.J. Dillon S. Maslesa-Galic'. Recombinant bacillus Calmette-Guerin (BCG) vaccines expressing the Mycobacterium tuberculosis 30-kDa major secretory protein induce greater protective immunity against tuberculosis than conventional BCG vaccines in a highly susceptible animal model Proc. Natl. Acad. Sci. USA 97 25 2000 13853 13858
22. P.J. Murray, A. Aldovini, and R.A. Young Manipulation and potentiation of antimycobacterial immunity using recombinant bacille Calmette-Guerin strains that secrete cytokines Proc. Natl. Acad. Sci. USA 93 2 1996 934 939
23. A.A. Chackerian, T.V. Perera, and S.M. Behar Gamma interferon-producing CD4+ T lymphocytes in the lung correlate with resistance to infection with Mycobacterium tuberculosis Infect. Immun. 69 4 2001 2666 2674
24. S.H. Kaufmann How can immunology contribute to the control of tuberculosis? Nat. Rev. Immunol. 1 1 2001 20 30
25. A.A. Chackerian, T.V. Perera, and S.M. Behar Gamma interferon-producing CD4+ T lymphocytes in the lung correlate with resistance to infection with Mycobacterium tuberculosis Infect. Immun. 69 4 2001 2666 2674
26. D.H. Canaday, R.J. Wilkinson, Q. Li, C.V. Harding, R.F. Silver, and W.H. Boom CD4+ and CD8+ T cells kill intracellular Mycobacterium tuberculosis by a perforin and Fas/Fas ligand-independent mechanism J. Immunol. 167 5 2001 2734 2742
27. N.V. Serbina, and J.L. Flynn CD8+ T cells participate in the memory immune response to Mycobacterium tuberculosis Infect. Immun. 69 7 2001 4320 4328
28. S.E. Dorman, and S.M. Holland Interferon-γ and interleukin-12 pathway defects and human disease Cytokine Growth Factor Rev. 11 4 2000 321 333
29. A.M. Cooper, D.K. Dalton, T.A. Stewart, J.P. Griffin, D.G. Russell, and I.M. Orme Disseminated tuberculosis in interferon gamma gene-disrupted mice J. Exp. Med. 178 6 1993 2243 2247
30. E.M. Agger, and P. Andersen Tuberculosis subunit vaccine development: on the role of interferon-γ Vaccine 19 17-19 2001 2298 2302
31. G.T. Seah, and G.A. Rook High levels of mRNA encoding IL-4 in unstimulated peripheral blood mononuclear cells from tuberculosis patients revealed by quantitative nested reverse transcriptase-polymerase chain reaction; correlations with serum IgE levels Scand. J. Infect. Dis. 33 2 2001 106 109
32. B. Bellete, J. Coberly, G.L. Barnes, C. Ko, R.E. Chaisson, G.W. Comstock, and W.R. Bishai Evaluation of a whole-blood interferon-gamma release assay for the detection of Mycobacterium tuberculosis infection in 2 study populations Clin. Infect. Dis. 34 11 2002 1449 1456
33. A. Wangoo, I.N. Brown, B.G. Marshall, H.T. Cook, D.B. Young, and R.J. Shaw Bacille Calmette-Guerin (BCG)-associated inflammation and fibrosis: modulation by recombinant BCG expressing interferon-gamma (IFN-γ) Clin. Exp. Immunol. 119 1 2000 92 98
34. P.J. Murray, A. Aldovini, and R.A. Young Manipulation and potentiation of antimycobacterial immunity using recombinant bacille Calmette-Guerin strains that secrete cytokines Proc. Natl. Acad. Sci. USA 93 2 1996 934 939
35. Y. Luo, X. Chen, R. Han, and M.A. O'Donnell Recombinant bacille Calmette-Gúrin (BCG) expressing human interferon-α 2B demonstrates enhanced immunogenicity Clin. Exp. Immunol. 123 2 2001 264 270
36. V.V. Yeremeev, G.R. Stewart, O. Neyrolles, K. Skrabal, V.G. Avdienko, A.S. Apt, and D.B. Young Deletion of the 19:kDa antigen does not alter the protective efficacy of BCG Tubercle Lung Dis. 80 6 2000 243 247
37. J.L. Flynn, and J. Chan Immunology of Tuberculosis Annu. Rev. Immunol. 19 1 2001 93 129
38. N.V. Serbina, V. Lazarevic, and J.L. Flynn CD4+ T cells are required for the development of cytotoxic CD8+ T cells during Mycobacterium tuberculosis infection J. Immunol. 167 12 2001 6991 7000
39. S.H. Kaufmann Is the development of a new tuberculosis vaccine possible? Nat. Med. 6 9 2004 955 960
40. U.E. Schaible, F. Winau, P.A. Sieling, K. Fischer, H.L. Collins, K. Hagens, R.L. Modlin, V. Brinkmann, and S.H. Kaufmann Apoptosis facilitates antigen presentation to T lymphocytes through MHC-I and CD1 in tuberculosis Nat. Med. 9 2003 1039 1046
41. P. Pancholi, A. Mirza, N. Bhardwaj, and R.M. Steinman Sequestration from immune CD4+ T cells of mycobacteria growing in human macrophages Science 260 2004 984 986
42. J. Hess, D. Miko, A. Catic, V. Lehmensiek, D.G. Russell, and S.H. Kaufmann Mycobacterium bovis bacille Calmette-Guerin strains secreting listeriolysin of Listeria monocytogenes Proc. Natl. Acad. Sci. USA 95 9 1998 5299 5304
43. J.E. Alouf, and C. Geoffroy Sourcebook of Bacterial Protein Toxins 1991 Academic Press London pp. 147-186
44. T. Jacobs, A. Darji, N. Frahm, M. Rohde, J. Wehland, T. Chakraborty, and S. Weiss Listeriolysin O: cholesterol inhibits cytolysis but not binding to cellular membranes Mol. Microbiol. 28 6 1998 1081 1089
45. J.C. Madden, N. Ruiz, and M. Caparon Cytolysin-Mediated Translocation (CMT): a functional equivalent of type III secretion in Gram-positive bacteria Cell 104 1 2001 143 152
46. I.J. Glomski, M.M. Gedde, A.W. Tsang, J.A. Swanson, and D.A. Portnoy The Listeria monocytogenes hemolysin has an acidic pH optimum to compartmentalize activity and prevent damage to infected host cells J. Cell Biol. 156 6 2002 1029 1038
47. M.A. Moors, B. Levitt, P. Youngman, and D.A. Portnoy Expression of listeriolysin O and ActA by intracellular and extracellular Listeria monocytogenes Infect. Immun. 67 1 1999 131 139
48. A. Bubert, Z. Sokolovic, S.K. Chun, L. Papatheodorou, A. Simm, and W. Goebel Differential expression of Listeria monocytogenes virulence genes in mammlian host cells Mol. Gen. Genet. 261 1999 323 336
49. A.L. Decatur, and D.A. Portnoy A PEST-Like sequence in listeriolysin O essential for Listeria monocytogenes pathogenicity Science 290 5493 2000 992 995
50. M.A. Lety, C. Frehel, I. Dubail, J.L. Beretti, S. Kayal, P. Berche, and A. Charbit Identification of a PEST-like motif in listeriolysin O required for phagosomal escape and for virulence in Listeria monocytogenes Mol. Microbiol. 39 5 2001 1124 1139
51. B. Sheehan, C. Kocks, S. Dramsi, E. Gouin, A.D. Klarsfeld, J. Mengaud, and P. Cossart Molecular and genetic determinants of the Listeria monocytogenes infectious process Curr. Top. Microbiol. Immunol. 192 1994 187 216
52. M.M. Gedde, D.E. Higgins, L.G. Tilney, and D.A. Portnoy Role of listeriolysin O in cell-to-cell spread of Listeria monocytogenes Infect. Immun. 68 2 2000 999 1003
53. S. Sturgill-Koszycki, P.H. Schlesinger, P. Chakraborty, P.L. Haddix, H.L. Collins, A.K. Fok, R.D. Allen, S.L. Gluck, J. Heuser, and D.G. Russell Lack of acidification in Mycobacterium phagosomes produced by exclusion of the vesicular proton-ATPase Science 263 2004 678 681
54. A.H. Gordon, P.D. Hart, and M.R. Young Ammonia inhibits phagosome-lysosome fusion in macrophages Nature 286 1980 79 80
55. H.L.T. Mobley, M.D. Island, and R.P. Hausinger Molecular biology of microbial ureases Microbiol. Rev. 59 1995 451 480
56. J. Reyrat, F. Berthet, and B. Gicquel The urease locus of Mycobacterium tuberculosis and Its utilization for the demonstration of allelic exchange in Mycobacterium bovis Bacillus Calmette-Guerin Proc. Natl. Acad. Sci. USA 92 19 1995 8768 8772
57. J.R. Glynn, J. Whiteley, P.J. Bifani, K. Kremer, and D. van Soolingen Worldwide Occurrence of Beijing/W Strains of Mycobacterium tuberculosis: a systematic review Emerg. Infect. Dis. 8 2002 843 849
58. A.G.M. van der Zanden, K. Kremer, L.M. Schouls, K. Caimi, A. Cataldi, A. Hulleman, N.J.D. Nagelkerke, and D. van Soolingen Improvement of differentiation and interpretability of spoligotyping for Mycobacterium tuberculosis complex isolates by introduction of new spacer oligonucleotides J. Clin. Microbiol. 40 12 2002 4628 4639
59. S.H.E. Kaufmann Immunity to intracellular bacteria Annu. Rev. Immunol. 11 1 1993 129 163
60. H.W. Rogers, M.P. Callery, B. Deck, and E.R. Unanue Listeria monocytogenes induces apoptosis of infected hepatocytes J. Immunol. 156 2 1996 679 684
61. K.D. Lee, Y.K. Oh, D.A. Portnoy, and J.A. Swanson Delivery of macromolecules into cytosol using liposomes containing hemolysin from Listeria monocytogenes J. Biol. Chem. 271 13 1996 7249 7252
62. T. Cirman, K. Oresic, G.D. Mazovec, V. Turk, J.C. Reed, R.M. Myers, G.S. Salvesen, and B. Turk Selective disruption of lysosomes in HeLa cells triggers apoptosis mediated by cleavage of Bid by multiple papain-like lysosomal cathepsins J. Biol. Chem. 279 5 2004 3578 3587
63. H.J. Mollenkopf, L. Grode, J. Mattow, M. Stein, P. Mann, B. Knapp, J. Ulmer, and S.H.E. Kaufmann Application of mycobacterial proteomics to vaccine design: improved protection by Mycobacterium bovis BCG prime-Rv3407 DNA boost vaccination against tuberculosis Infect. Immun. 72 11 2004 6471 6479
64. M.A. Chambers, A. Williams, D. Gavier-Widen, A. Whelan, G. Hall, P.D. Marsh, B.R. Bloom, W.R. Jacobs, and R.G. Hewinson Identification of a Mycobacterium bovis BCG auxotrophic mutant that protects guinea pigs against M. bovis and hematogenous spread of Mycobacterium tuberculosis without sensitization to tuberculin Infect. Immun. 68 12 2000 7094 7099
65. F. Berthet, M. Lagranderie, P. Gounon, C. Laurent-Winter, D. Ensergueix, P. Chavarot, F. Thouron, E. Maranghi, V. Pelicic, D. Portnoï, G. Marchal, and B. Gicquel Attenuation of virulence by disruption of the Mycobacterium tuberculosis erp gene Science 282 5389 1998 759 762
66. I. Guleria, R. Teitelbaum, R.A. McAdam, G. Kalpana, W.R. Jacobs, and B.R. Bloom Auxotrophic vaccines for tuberculosis Nat. Med. 2 3 1996 334 337
67. Y. Yuan, D.D. Crane, R.M. Simpson, Y. Zhu, M.J. Hickey, D.R. Sherman, and C.E. Barry III The 16-kDa alpha-crystallin (Acr) protein of Mycobacterium tuberculosis is required for growth in macrophages Proc. Natl. Acad. Sci. USA 95 16 1998 9578 9583
68. M.A. Horwitz, G. Harth, and B.J. Dillon S. Maslesa-Galic'. Recombinant bacillus Calmette-Guerin (BCG) vaccines expressing the Mycobacterium tuberculosis 30-kDa major secretory protein induce greater protective immunity against tuberculosis than conventional BCG vaccines in a highly susceptible animal model Proc. Natl. Acad. Sci. USA 97 25 2000 13853 13858